RAG2
V(D)J recombination-activating protein 2
Also known as: RAG2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55895
- Gene
- RAG2
- Ensembl
- ENSG00000175097
- Chromosome
- 11
- Canonical length
- 527 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a protein that is involved in the initiation of V(D)J recombination during B and T cell development. This protein forms a complex with the product of the adjacent recombination activating gene 1, and this complex can form double-strand breaks by cleaving DNA at conserved recombination signal sequences. The recombination activating gene 1 component is thought to contain most of the catalytic activity, while the N-terminal of the recombination activating gene 2 component is thought to form a six-bladed propeller in the active core that serves as a binding scaffold for the tight association of the complex with DNA. A C-terminal plant homeodomain finger-like motif in this protein is necessary for interactions with chromatin components, specifically with histone H3 that is trimethylated at lysine 4. Mutations in this gene cause Omenn syndrome, a form of severe combined immunodeficiency associated with autoimmune-like symptoms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
527 residues, UniProt reviewed canonical sequence.
>P55895|RAG2
1 MSLQMVTVSN NIALIQPGFS LMNFDGQVFF FGQKGWPKRS CPTGVFHLDV KHNHVKLKPT
61 IFSKDSCYLP PLRYPATCTF KGSLESEKHQ YIIHGGKTPN NEVSDKIYVM SIVCKNNKKV
121 TFRCTEKDLV GDVPEARYGH SINVVYSRGK SMGVLFGGRS YMPSTHRTTE KWNSVADCLP
181 CVFLVDFEFG CATSYILPEL QDGLSFHVSI AKNDTIYILG GHSLANNIRP ANLYRIRVDL
241 PLGSPAVNCT VLPGGISVSS AILTQTNNDE FVIVGGYQLE NQKRMICNII SLEDNKIEIR
301 EMETPDWTPD IKHSKIWFGS NMGNGTVFLG IPGDNKQVVS EGFYFYMLKC AEDDTNEEQT
361 TFTNSQTSTE DPGDSTPFED SEEFCFSAEA NSFDGDDEFD TYNEDDEEDE SETGYWITCC
421 PTCDVDINTW VPFYSTELNK PAMIYCSHGD GHWVHAQCMD LAERTLIHLS AGSNKYYCNE
481 HVEIARALHT PQRVLPLKKP PMKSLRKKGS GKILTPAKKS FLRRLFDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 140 nTPM
Expression across tissuesHPA
Tissue
- thymus: 140 nTPM
- thyroid gland: 22 nTPM
- bone marrow: 1.3 nTPM
- testis: 0.9 nTPM
- tonsil: 0.3 nTPM
- choroid plexus: 0.1 nTPM
Single-cell type
- cardiomyocytes: 27 nCPM
- adipocytes: 9 nCPM
- late primary spermatocytes: 4.9 nCPM
- epicardial cells: 4.5 nCPM
- choroid plexus epithelial cells: 4 nCPM
- fibro-adipogenic progenitors: 2.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 0.5 nTPM
- cerebral cortex: 0.1 nTPM
- thalamus: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RAG2.
Disease | AllUniProt
Conditions RAG2 is implicated in, by any mechanism.
- Combined cellular and humoral immune defects with granulomas (CHIDG) MIM:233650
- Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) MIM:601457
- Omenn syndrome (OS) MIM:603554
Disease | GeneticClinVar
146 pathogenic / likely-pathogenic of 628 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined immunodeficiency with skin granulomas
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive
- Histiocytic medullary reticulosis
- Recombinase activating gene 2 deficiency
- Inborn error of immunity
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- B cell homeostatic proliferation
- B cell lineage commitment
- defense response to bacterium
- DN2 thymocyte differentiation
- mature B cell differentiation involved in immune response
- negative regulation of T cell differentiation in thymus
- organ growth
- positive regulation of organ growth
- pre-B cell allelic exclusion
- T cell differentiation in thymus
- T cell lineage commitment
- V(D)J recombination
Molecular functions
- chromatin binding
- histone H3K4me3 reader activity
- phosphatidylinositol binding
- phosphatidylinositol-3,4,5-trisphosphate binding
- phosphatidylinositol-3,4-bisphosphate binding
- phosphatidylinositol-3,5-bisphosphate binding
- phosphatidylinositol-4,5-bisphosphate binding
- sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, FYVE/PHD-type
- Galactose oxidase/kelch, beta-propeller
- Kelch-type beta-propeller
- V-D-J recombination activating protein 2
- Recombination activating protein 2, PHD domain
- Recombination activating protein 2
- RAG2 PHD domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAG2 as an antibody target. Whether an autoantibody or antibody against RAG2 could matter depends on whether native RAG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAG2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Mutations in this gene cause Omenn syndrome, a form of severe combined immunodeficiency associated with autoimmune-like symptoms.
Loading the interactive Seroatlas protein explorer...